Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)Custom crystal commemorative celebrating the launch of Wynzora Cream, a topical treatment for plaque psoriasis that received approval from the FDA (Food and Drug Administration) in 2020. The product launch resulted from a collaboration agreement between Denmark-based MC2 Therapeutics, and EPI Health, a specialty pharmaceutical firm headquartered in Charleston, South Carolina.
(21ADH022)Lucite embedment with drug vial commemorating a study of a treatment for solid tumor cancer.
(21ADH006)Crystal commemorative celebrating a development and commercialization agreement between Click Therapeutics and pharmaceutical firm Boehringer Ingelheim. The partnership centers on a mobile prescription app providing digital treatment for patients with schizophrenia.
(21AKL599)Custom Lucite award to speakers at Ladenburg Thalmann’s Virtual Tech Expo, held in November, 2021. The conference included approximately 50 technology companies, and addressed topics such as connectivity, cybersecurity, mobility, and virtual and augmented reality.
(22AJH004)Custom Lucite with Florida Shape
